| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CDMO(元) | 16,443,432.56 | - | 27,811,600.00 | 80,320,700.00 | 59,198,619.72 |
| 标准肝素原料(元) | 84,252,769.02 | 400,730,572.52 | 290,750,600.00 | 787,139,800.00 | 532,521,159.44 |
| 制剂(元) | 1,818,769,479.66 | 3,515,786,253.71 | 1,658,715,100.00 | 3,050,268,300.00 | 1,547,734,824.15 |
| CDMO及其他(元) | - | 68,607,366.66 | - | - | - |
| 营业成本(元) | |||||
| CDMO(元) | 15,138,726.36 | - | 14,218,500.00 | 27,401,500.00 | 34,809,870.04 |
| 标准肝素原料(元) | 71,971,951.55 | 284,774,069.98 | 197,847,100.00 | 548,717,100.00 | 377,951,044.62 |
| 制剂(元) | 1,187,619,027.73 | 2,095,885,096.63 | 1,022,077,200.00 | 1,646,021,100.00 | 865,110,972.64 |
| CDMO及其他(元) | - | 29,699,801.64 | - | - | - |
| 毛利(元) | |||||
| CDMO(元) | 1,304,706.20 | - | 13,593,100.00 | 52,919,200.00 | 24,388,749.68 |
| 标准肝素原料(元) | 12,280,817.47 | 115,956,502.54 | 92,903,500.00 | 238,422,700.00 | 154,570,114.82 |
| 制剂(元) | 631,150,451.93 | 1,419,901,157.08 | 636,637,900.00 | 1,404,247,200.00 | 682,623,851.51 |
| CDMO及其他(元) | - | 38,907,565.02 | - | - | - |
| 毛利率(%) | |||||
| CDMO(%) | 7.93 | - | 48.88 | 65.88 | 41.20 |
| 标准肝素原料(%) | 14.58 | 28.94 | 31.95 | 30.29 | 29.03 |
| 制剂(%) | 34.70 | 40.39 | 38.38 | 46.04 | 44.10 |
| CDMO及其他(%) | - | 56.71 | - | - | - |
| 收入构成(%) | |||||
| CDMO(%) | 0.86 | - | 1.41 | 2.05 | 2.77 |
| 标准肝素原料(%) | 4.39 | 10.06 | 14.70 | 20.09 | 24.89 |
| 制剂(%) | 94.75 | 88.22 | 83.89 | 77.86 | 72.34 |
| CDMO及其他(%) | - | 1.72 | - | - | - |
| 毛利构成(%) | |||||
| CDMO(%) | 0.20 | - | 1.83 | 3.12 | 2.83 |
| 标准肝素原料(%) | 1.90 | 7.36 | 12.50 | 14.06 | 17.94 |
| 制剂(%) | 97.89 | 90.17 | 85.67 | 82.82 | 79.23 |
| CDMO及其他(%) | - | 2.47 | - | - | - |